D-Street Talk podcast: ‘Last few days have been traders’ nightmare’, regulation a bigger concern

This is a market in which you could lose a lot of money if you miss your move because market moves are swift. The only thing to focus on is to maintain strict stop losses and position sizing.

Kshitij Anand

April 06, 2020 / 17:33 IST

Indian market have witnessed a vertical fall since January, pushing benchmark indices in bear territory, but last few days have been traders’ nightmare, Kunal Saraogi, CEO at Equity Rush told Moneycontrol in a special podcast D-Street Talk.

“We have seen markets opening with a gap down of 400 points and they continue to go down 1,000 points on the Nifty right before we saw market freeze – these are scary scenarios,” he said.

Saraogi further elaborated that the thing which spooked him the most is not the movement of the markets, but the regulatory action. “There is a constant fear that will the markets operate the next day. There could be a complete lockdown or there could be a ban on short selling,” explains Saraogi.

He further added that one part of my strategy is trade with long-short positions where short positions are made on the stocks that are underperforming and to hedge the risk long positions are made on stocks that are outperforming.

If you have short positions – the biggest worry is that if you don’t exit and the next day there is a ban on short-covering is nerve-racking.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

D-Street Talk podcast: ‘Last few days have been traders’ nightmare’, regulation a bigger concern

This is a market in which you could lose a lot of money if you miss your move because market moves are swift. The only thing to focus on is to maintain strict stop losses and position sizing.

Related stories

Subscribe to Tech Newsletters

D-Street Talk podcast: ‘Last few days have been traders’ nightmare’, regulation a bigger concern

This is a market in which you could lose a lot of money if you miss your move because market moves are swift. The only thing to focus on is to maintain strict stop losses and position sizing.

Related stories

Subscribe to Tech Newsletters

Trending news